Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.

Page M, Stebbings R, Berry N, Hull R, Ferguson D, Davis L, Duffy L, Elsley W, Hall J, Ham C, Hassall M, Li B, Mee ET, Quartey-Papafio R, Rose NJ, Mathy N, Voss G, Stott EJ, Almond N.

Retrovirology. 2012 Jul 16;9:56. doi: 10.1186/1742-4690-9-56.

2.

Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo.

Ferguson D, Wade-Evans A, Elsley W, Sangster R, Silvera P, MacManus S, Davis G, Corcoran T, Berry N, Brown S, Jenkins A, Cowie J, Sethi M, Hull R, Stebbings R, Lines J, Norley S, Stott EJ, Almond N.

J Med Primatol. 2007 Jun;36(3):131-42.

PMID:
17517087
3.

Mechanisms of protection induced by attenuated simian immunodeficiency virus.

Stebbings RJ, Almond NM, Stott EJ, Berry N, Wade-Evans AM, Hull R, Lines J, Silvera P, Sangster R, Corcoran T, Rose J, Walker KB.

Virology. 2002 May 10;296(2):338-53.

4.

In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo.

Cantó-Nogués C, Jones S, Sangster R, Silvera P, Hull R, Cook R, Hall G, Walker B, Stott EJ, Hockley D, Almond N.

J Gen Virol. 2001 Sep;82(Pt 9):2225-34.

PMID:
11514733
5.

Construction of infectious SIV/HIV-2 chimeras.

Ranjbar S, Bhattacharya U, Oram J, Stott EJ, Almond N.

AIDS. 2000 Nov 10;14(16):2479-84.

PMID:
11101058
6.

The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus.

Almond N, Jenkins A, Jones S, Arnold C, Silvera P, Kent K, Mills KH, Stott EJ.

J Gen Virol. 1999 Sep;80 ( Pt 9):2375-82.

PMID:
10501490
7.

Monoclonal antibodies recognize at least five epitopes on the SIV Nef protein and identify an in vitro-induced mutation.

Arnold C, Jenkins A, Almond N, Stott EJ, Kent KA.

AIDS Res Hum Retroviruses. 1999 Aug 10;15(12):1087-97.

PMID:
10461829
8.

Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus.

Montgomery MM, Dean AF, Taffs F, Stott EJ, Lantos PL, Luthert PJ.

Neuropathol Appl Neurobiol. 1999 Feb;25(1):11-9.

PMID:
10194771
9.

Changes in neuron size in cynomolgus macaques infected with various immunodeficiency viruses and poliovirus.

Montgomery MM, Wood A, Stott EJ, Sharp C, Luthert PJ.

Neuropathol Appl Neurobiol. 1998 Dec;24(6):468-75.

PMID:
9888157
10.

Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus.

Stott EJ, Almond N, Kent K, Walker B, Hull R, Rose J, Silvera P, Sangster R, Corcoran T, Lines J, Silvera K, Luciw P, Murphy-Corb M, Momin P, Bruck C.

J Gen Virol. 1998 Mar;79 ( Pt 3):423-32.

PMID:
9519819
11.

Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.

Almond N, Rose J, Sangster R, Silvera P, Stebbings R, Walker B, Stott EJ.

J Gen Virol. 1997 Aug;78 ( Pt 8):1919-22.

PMID:
9266988
12.

The construction and evaluation of SIV/HIV chimeras that express the envelope of European HIV type 1 isolates.

Ranjbar S, Jones S, Stott EJ, Almond N.

AIDS Res Hum Retroviruses. 1997 Jun 10;13(9):797-800.

PMID:
9171224
13.

Cytokine profiling of simian immunodeficiency virus infection of cynomologus macaques. Pathogenic SIVmac251 pJ5C versus non-pathogenic attenuated SIVmac251 pC8C reveals divergence.

Stabbings RJ, Lines JL, Almond NM, Stott EJ, Walker KB.

Biochem Soc Trans. 1997 May;25(2):285S. No abstract available.

PMID:
9191329
14.

Comparison of peripheral blood phenotype in pathogenic and attenuated SIV infection.

Lines JL, Walker KB, Almond NM, Stott EJ, Stebbings RJ.

Biochem Soc Trans. 1997 May;25(2):284S. No abstract available.

PMID:
9191328
15.

Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells.

Almond N, Corcoran T, Hull R, Walker B, Rose J, Sangster R, Silvera K, Silvera P, Cranage M, Rud E, Stott EJ.

J Med Primatol. 1997 Feb-Apr;26(1-2):34-43.

PMID:
9271187
16.

Strategies for AIDS vaccines.

Stott EJ, Schild GC.

J Antimicrob Chemother. 1996 May;37 Suppl B:185-98. Review.

PMID:
8818840
17.

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

Almond N, Kent K, Cranage M, Rud E, Clarke B, Stott EJ.

Lancet. 1995 May 27;345(8961):1342-4.

PMID:
7752758
18.

Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.

Silvera P, Flanagan B, Kent K, Rud E, Powell C, Corcoran T, Bruck C, Thiriart C, Haigwood NL, Stott EJ.

AIDS Res Hum Retroviruses. 1994 Oct;10(10):1295-304.

PMID:
7848685
19.

Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.

Choi WS, Collignon C, Thiriart C, Burns DP, Stott EJ, Kent KA, Desrosiers RC.

J Virol. 1994 Sep;68(9):5395-402.

20.

Towards a vaccine against AIDS: lessons from simian immunodeficiency virus vaccines.

Stott EJ.

Curr Top Microbiol Immunol. 1994;188:221-37. Review. No abstract available.

PMID:
7924428
21.

Where are we now with vaccines against AIDS?

Schild GC, Stott EJ.

BMJ. 1993 Apr 10;306(6883):947-8.

22.

Neutralizing antibodies modulate replication of simian immunodeficiency virus SIVmac in primary macaque macrophages.

McEntee MF, Zink MC, Anderson MG, Farzadegan H, Adams RJ, Kent KA, Stott EJ, Clements JE, Narayan O.

J Virol. 1992 Oct;66(10):6200-3.

23.

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.

Arbiza J, Taylor G, López JA, Furze J, Wyld S, Whyte P, Stott EJ, Wertz G, Sullender W, Trudel M, et al.

J Gen Virol. 1992 Sep;73 ( Pt 9):2225-34.

PMID:
1383404
24.

Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.

Taylor G, Stott EJ, Furze J, Ford J, Sopp P.

J Gen Virol. 1992 Sep;73 ( Pt 9):2217-23.

PMID:
1383403
25.

Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.

Panicali DL, Mazzara G, Sullivan JL, Hesselton R, Shen L, Letvin N, Daniel M, Desrosiers R, Stott EJ.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1449. No abstract available.

PMID:
1466979
26.

Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.

Kent KA, Rud E, Corcoran T, Powell C, Thiriart C, Collignon C, Stott EJ.

AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51.

PMID:
1380261
28.

Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.

Mills KH, Page M, Chan WL, Kitchin P, Stott EJ, Taffs F, Jones W, Rose J, Ling C, Silvera P, et al.

J Med Primatol. 1992 Feb-May;21(2-3):50-8.

PMID:
1433267
29.

Transmission studies with simian immunodeficiency virus of macaques; persistent infection of baboons.

Cranage MP, Cook N, Stott EJ, Cook R, Baskerville A, Greenaway PJ.

Intervirology. 1992;34(2):53-61.

PMID:
1293067
30.

Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.

Mills KH, Barnard AL, Williams M, Page M, Ling C, Stott EJ, Silvera P, Taffs F, Kingsman AS, Adams SE, et al.

J Immunol. 1991 Nov 15;147(10):3560-7.

PMID:
1719081
31.

The quest for vaccines against AIDS: progress and challenges. An overview.

Schild GC, Stott EJ.

Vaccine. 1991 Nov;9(11):779-81. Review. No abstract available.

PMID:
1759497
32.

Anti-cell antibody in macaques.

Stott EJ.

Nature. 1991 Oct 3;353(6343):393. No abstract available.

PMID:
1815549
33.

Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.

Kent KA, Gritz L, Stallard G, Cranage MP, Collignon C, Thiriart C, Corcoran T, Silvera P, Stott EJ.

AIDS. 1991 Jul;5(7):829-36.

PMID:
1716442
34.
36.

Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.

Trudel M, Stott EJ, Taylor G, Oth D, Mercier G, Nadon F, Séguin C, Simard C, Lacroix M.

Arch Virol. 1991;117(1-2):59-71.

PMID:
1706591
37.

Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine.

Stott EJ, Chan WL, Mills KH, Page M, Taffs F, Cranage M, Greenaway P, Kitchin P.

Lancet. 1990 Dec 22-29;336(8730):1538-41.

PMID:
1979369
38.

Histopathological changes in simian immunodeficiency virus infection.

Baskerville A, Ramsay A, Cranage MP, Cook N, Cook RW, Dennis MJ, Greenaway PJ, Kitchin PA, Stott EJ.

J Pathol. 1990 Sep;162(1):67-75.

PMID:
2231195
39.

The use of the polymerase chain reaction for the detection of Simian immunodeficiency virus in experimentally infected macaques.

Kitchin PA, Almond N, Szotyori Z, Fromholc CE, McAlpine L, Silvera P, Stott EJ, Cranage M, Baskerville A, Schild G.

J Virol Methods. 1990 Apr;28(1):85-99.

PMID:
2161421
40.
42.

Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus.

Kennedy HE, Jones BV, Tucker EM, Ford NJ, Clarke SW, Furze J, Thomas LH, Stott EJ.

J Gen Virol. 1988 Dec;69 ( Pt 12):3023-32.

PMID:
3199102
43.
44.
45.

Field trial of a quadrivalent vaccine against calf respiratory disease.

Stott EJ, Thomas LH, Howard CJ, Gourlay RN.

Vet Rec. 1987 Oct 10;121(15):342-7.

PMID:
2825397
46.
47.
48.

Lymphocyte transformation response of calves to respiratory syncytial virus.

Taylor G, Stott EJ, Thomas LH.

J Med Virol. 1987 Aug;22(4):333-44.

PMID:
3498008
49.

Supplemental Content

Loading ...
Support Center